Extension to the EMA’s Multinational Assessment Team Initiative as of April 2017
20 February 2017Focus on Regulation
Starting in April 2017, the European Medicines Agency (“EMA”) will expand the Multinational Assessment Team (“MNAT”) Initiative to post-authorisation assessments. From this date, the MNAT Initiative will allow national competent authorities not only to participate actively in the development of new medicinal products, but also to be involved in the extensions of marketing authorisations for existing medicinal products.
To read more, click here.